Skip to main content

Morphine, Th1/Th2 Differentiation, and Susceptibility to Infection

  • Chapter
Infectious Diseases and Substance Abuse

Part of the book series: Infectious Agents and Pathogenesis ((IAPA))

8. Summary and Conclusion

Chronic morphine treatment has been shown to alter a number of immune parameters including suppression of cellular immunity. We speculate that differentiation of T helper to Th2 effector cells may be a major contributing factor to impaired cellular immunity following chronic morphine treatment. Our results show that chronic morphine treatment in vitro directs T-helper cells toward Th2 differentiation. We also show that chronic morphine treatment differentially modulates the transcriptional “switches” GATA3 and T-bet, thus providing a molecular mechanism by which morphine directs CD4+ differentiation. These studies suggest that therapies that prevent Th2 differentiation and promote Th1 cytokine synthesis may therefore prove beneficial in the immuno-suppressed drug abuse population.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cantacuzene, J. (1898). Nouvelles recherches sur le monde de destruction des vibrions dans l’organisme. Ann. Inst. Pasteur 12:273–300.

    Google Scholar 

  2. Brown, S. M., Stimmel, B., Taub, R. N., Kochwa, S., and Rosenfeld, R. E. (1974). Immunological dysfunction in heroin addicts. Arch. Intern. Med. 134:1001–1006.

    Article  PubMed  CAS  Google Scholar 

  3. Louria, D. B., Hensle, T., and Rose, J. (1974). The major medical complications of heroin addiction. Ann. Int. Med. 67:1–22.

    Google Scholar 

  4. McDonough. R. J., Madden. J. J., Falek. A., Shafer. D. A., Pline, M., Gordon. D. et al (1980). Alterations of T and null lymphocyte frequencies in the peripheral blood of human opiate addicts. J. Immunol. 125:2539.

    PubMed  CAS  Google Scholar 

  5. Wybran, J., Appelboon, T., Famey, J. P., and Govaerts, A. (1979). Suggestive evidence for receptors for morphine and methionine enkephalin on normal human blood T-lymphocytes. J. Immunol. 123:1068–1070.

    PubMed  CAS  Google Scholar 

  6. Roy, S. and Loh, H. H. (1996, November). Effects of opioids on the immune system. Neurochem. Res. 21(11):1375–1386, review.

    PubMed  CAS  Google Scholar 

  7. Peng, X., Mosser, D. M., Adler, M. W., Rogers, T. J., Meissler, J. J., Jr, and Eisenstein, T. K. (2000, November). Morphine enhances interleukin-12 and the production of other pro-inflammatory cytokines in mouse peritoneal macrophages. J. Leukoc. Biol. 68(5):723–728.

    PubMed  CAS  Google Scholar 

  8. Wang, J., Charboneau, R., Balasubramanian, S., Barke, R. A., Loh, H. H., and Roy, S. (2001, October). Morphine modulates lymph node-derived T lymphocyte function: Role of caspase-3,-8, and nitric oxide. J. Leukoc. Biol. 70(4):527–536.

    PubMed  CAS  Google Scholar 

  9. Limiroli, E., Gaspani, L., Panerai, A. E., and Sacerdote, P. (2002, July). Differential morphine tolerance development in the modulation of macrophage cytokine production in mice. J. Leukoc. Biol. 72(1):43–48.

    PubMed  CAS  Google Scholar 

  10. Guo, C. J., Li, Y., Tian, S., Wang, X., Douglas, S. D., and Ho, W. Z. (2002, November). Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor. J. Investig. Med. 50(6):435–442.

    PubMed  CAS  Google Scholar 

  11. Singhal, P. C., Kapasi, A. A., Reddy, K., Franki, N., Gibbons, N., and Ding, G. (1999, October). Morphine promotes apoptosis in Jurkat cells. J. Leukoc. Biol. 66(4):650–658.

    PubMed  CAS  Google Scholar 

  12. Singhal, P. C., Kapasi, A. A., Franki, N., and Reddy, K. (2000, May). Morphine-induced macrophage apoptosis: The role of transforming growth factor-beta. Immunology 100(1):57–62.

    Article  PubMed  CAS  Google Scholar 

  13. Singhal, P. C., Bhaskaran, M., Patel, J., Patel, K., Kasinath, B. S., Duraisamy, S. et al. (2002, April 15). Role of p38 mitogen-activated protein kinase phosphorylation and Fas-Fas ligand interaction in morphine-induced macrophage apoptosis. J. Immunol. 168(8):4025–4033.

    PubMed  CAS  Google Scholar 

  14. Singhal, P., Kapasi, A., Reddy, K., and Franki, N. (2001). Opiates promote T cell apoptosis through JNK and caspase pathway. Adv. Exp. Med. Biol. 493:127–135.

    PubMed  CAS  Google Scholar 

  15. Roy, S., Balasubramanian, S., Sumandeep, S., Charboneau, R., Wang, J., Melnyk, D. et al. (2001, August). Morphine directs T cells toward T(H2) differentiation. Surgery 130(2):304–309.

    Article  PubMed  CAS  Google Scholar 

  16. Peterson, P. K., Gekker, G., Brummitt, C., Pentel, P., Bullock, M., Simpson, M. et al. (1989, March). Suppression of human peripheral blood mononuclear cell function by methadone and morphine. J. Infect. Dis. 159(3):480–487.

    PubMed  CAS  Google Scholar 

  17. Suzuki, S., Chuang, L. F., Yau, P., Doi, R. H, and Chuang, R. Y. (2002, November 1). Interactions of opioid and chemokine receptors: Oligomerization of mu, kappa, and delta with CCR5 on immune cells. Exp. Cell Res. 280(2):192–200.

    Article  PubMed  CAS  Google Scholar 

  18. Suzuki, S., Miyagi, T., Chuang, T. K., Chuang, L. F., Doi, R. H., and Chuang, R. Y. (2000, December 20). Morphine upregulates mu opioid receptors of human and monkey lymphocytes. Biochem. Biophys. Res. Commun. 279(2):621–628.

    Article  PubMed  CAS  Google Scholar 

  19. Abbas, A., Murphy, K. M., and Sher, A. (1996). Functional diversity of helper T lymphocytes. Nature 383:787–793.

    Article  PubMed  CAS  Google Scholar 

  20. Grogan, J. L. and Locksley, R. M. (2002). T helper cell differentiation: On again, off again. Curr. Opin. Immunol. 14:366–372.

    Article  PubMed  CAS  Google Scholar 

  21. O’Connor, P. G., Shi, J. M., Henry, S., Durante, A. J., Friedman, L., and Selwyn, P. A. (1999, July). Tuberculosis chemoprophylaxis using a liquid isoniazid-methadone admixture for drug users in methadone maintenance. Addiction 94(7):1071–1075.

    Article  PubMed  CAS  Google Scholar 

  22. Ray, A. and Cohn, L. (1999). Th2 cell and GATA3 in asthma: New insights into the regulation of airway inflammation. J. Clin. Invest. 104(8):985–993.

    PubMed  CAS  Google Scholar 

  23. Mullen, A. C., High, F. A., Hutchins, A. S. et al. (2001). Role of T-bet in commitment of Th1 cells before IL-12 dependent selection. Science 292:1907–1910.

    Article  PubMed  CAS  Google Scholar 

  24. Robinson, D. S. and O’Garra, A. (2002). Further checkpoints in Th1 development. Immunity 16:755–758.

    Article  PubMed  CAS  Google Scholar 

  25. Afkarian, M., Sedy, J. R., and Yang, J. et al. (2002, June). T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells [see comments]. Comment in: Nat. Immunol. 3(6):506–508, 549–557.

    Article  CAS  Google Scholar 

  26. Dong, C., and Flavell, R. A. (2002). Control of T helper cell differentiation-in search of master genes, Science 1–5.

    Google Scholar 

  27. Flavell, R. A, Li, B., Dong, C., Lu, H. T., Yang, D. D., Enslen, H. et al. (1999). Molecular basis of T-cell differentiation. Cold Spring Harbor Symposia on Quantitative Biology, Vol LXIV, Cold Spring Harbor Laboratory Press, 0-87969-569-2/99, pp. 563–571.

    Article  Google Scholar 

  28. Losman, J., Chen, H., Jiang, P. et al. (1999). IL-4 signaling is regulated through the recruitment of phosphatases, kinases, and SOCS proteins to the receptor complex. Cold Spring Harbor Symposia on Quantitative Biology, Vol LXIV, Cold Spring Harbor Laboratory Press, 0-87969-569-2/99.

    Google Scholar 

  29. O’Garra, A. and Arai, N. (2000). The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol. 10:542–550.

    Article  PubMed  CAS  Google Scholar 

  30. Ranganath, S., Ouyang, W., Bhattarcharya, D., Sha, W. C., Grupe, A., Peltz, G. et al. (1998, October 15). GATA3-dependent enhancer activity in IL-4 gene regulation. J. Immunol. 161(8):3822–3826.

    PubMed  CAS  Google Scholar 

  31. Szabo, S. J., Kim, S. T., Costa, G. L., Zhang, X., Fathman, C. G., and Glimcher, L. H. (2000). A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100:655–669.67. Zhang, D.H., Yang, L., and Ray, A. (1998). Differential responsiveness of the IL-5 and IL-5 genes to transcription factor GATA3. J. Immunol. 161:3817.

    Article  PubMed  CAS  Google Scholar 

  32. Arai, N., Lee, H. J., and Ferber, I. et al. (1999). Multiple levels of regulation of Th2 cytokine gene expression. Cold Spring Harbor Symposia on Quantitative Biology, Vol LXIV, Cold Spring Harbor Laboratory Press, 0-87969-569-2/99.

    Google Scholar 

  33. Ho, I. C., Kim, J. I., Szabo, S. J., and Glimcher, L. H. (1999). Tissue specific regulation of cytokine gene expression. Cold Spring Harbor Symposia on Quantitative Biology, Vol LXIV, Cold Spring Harbor Laboratory Press, 0-87969-569-2/99, pp. 573–584.

    Article  Google Scholar 

  34. Ouyang, W., Lohning, M., Gao, Z., Assenmacher, M., Ranganath, S., Radbruch, A. et al. (2000, January). Stat6-independent GATA3 autoactivation directs IL-4-independent Th2 development and commitment. Immunity 12(1):27–37.

    Article  PubMed  CAS  Google Scholar 

  35. Ranganath, S. and Murphy, K. M. (2001, April). Structure and specificity of GATA proteins in Th2 development. Mol. Cell. Biol. 21(8):2716–2725.

    Article  PubMed  CAS  Google Scholar 

  36. Takeda, K., Tanaka, T., Shi, W., Matsumoto, M., Minami, M., Kashiwamura, S.-I. et al. (1996). Essential role of Stat6 in IL-4 signaling. Nature 380:627–630.

    Article  PubMed  CAS  Google Scholar 

  37. Dent, A. L., Shaffer, A. L., Yu, X., Allman, D., and Staudt, L. M. (1997). Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 276:589–592.

    Article  PubMed  CAS  Google Scholar 

  38. Kaplan, M. H. and Grusby, M. J. (1998, July). Regulation of T helper cell differentiation by STAT molecules. J. Leukoc. Biol. 64(1):2–5.

    PubMed  CAS  Google Scholar 

  39. Muraille, E. and Leo, O. (1998). Revisiting the Th1/Th2 paradigm. Scand. J. Immunol. 47:1–9.

    Article  PubMed  CAS  Google Scholar 

  40. Gorelik, L., Fields, P. et al. (2000). Cutting edge: TGF-b inhibits Th type 2 development through inhibition of GATA3 expression. J. Immunol. 165:4773–4777.

    PubMed  CAS  Google Scholar 

  41. Kurata, H., Lee, H. J., O’Garra, A., and Arai, N. (1999). Ectopic expression of activated stat6 induces the expression of Th2 specific cytokines and transcription factors in developing Th1 cells. Immunity 11:677–688.

    Article  PubMed  CAS  Google Scholar 

  42. Kraus, J., Borner, C., Giannini, E., Hickfang, K., Braun, H., Mayer, P. et al. (2001). Regulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site. J. Biol. Chem. 23;276(47):43901–43908.

    Article  PubMed  CAS  Google Scholar 

  43. Sacerdote, P., San Secondo, VEMR. Sirchia, G., Manfredi, B., and Panerai, A. E. (1998). Endogenous opioids modulate allograft rejection time in mice: Possible relation with Th1/Th2 cytokines. Clin. Exp. Immunol. 113:465–469.

    Article  PubMed  CAS  Google Scholar 

  44. Sacerdote, P., Bianchi, M., and Panerai, A. E. (1996). Regul. Pept. 63:79.

    Article  PubMed  CAS  Google Scholar 

  45. Moynihan, J. A., Karp, J. D., Cohen, N., and Ader, R., (2000, January 24). Immune deviation following stress odor exposure: Role of endogenous opioids. J. Neuroimmunol. 102(2):145–153.

    Article  PubMed  CAS  Google Scholar 

  46. Berkenbosch, F., Vermes, I., and Tilders, F. J. (1984, September). The beta-adrenoceptorblocking drug propranolol prevents secretion of immunoreactive beta-endorphin and alpha-melanocyte-stimulating hormone in response to certain stress stimuli. Endocrinology 115(3):1051–1059.

    Article  PubMed  CAS  Google Scholar 

  47. Nelson, C. J., Carrigan, K. A., and Lysle, D. T. (2000). Naltrexone administration attenuates surgery-induced immune alterations in rats. J. Surg. Res. 94(2):172–177.

    Article  PubMed  CAS  Google Scholar 

  48. Yin, D., Tuthill, D., Mufson, R. A., and Shi, Y. (2000, April 17). Chronic restraint stress promotes lymphocyte apoptosis by modulating CD95 expression. J. Exp. Med. 191(8):1423–1428.

    Article  PubMed  CAS  Google Scholar 

  49. Van den Bergh, P., Rozing, J., and Nagelkerken, L. (1994, April). Identification of distinct sites of beta-endorphin that stimulate lymphokine production by murine CD4+ T cells. Lymphokine Cytokine Res. 13(2):63–69.

    PubMed  Google Scholar 

  50. Van den Bergh, P., Dobber, R., Ramlal, S., Rozing, J., and Nagelkerken L. (1994, March). Role of opioid peptides in the regulation of cytokine production by murine CD4+ T cells. Cell. Immunol. 154(1):109–122.

    Article  PubMed  Google Scholar 

  51. Van den Bergh, P., Rozing, J., and Nagelkerken, L. (1993, June). Beta-endorphin stimulates Ia expression on mouse B cells by inducing interleukin-4 secretion by CD4+ T cells. Cell. Immunol. 149(1):180–192.

    Article  PubMed  Google Scholar 

  52. Roy, S., Balasubramanian, S., Sumandeep, S., Charboneau, R., Wang, J., Melnyk, D. et al. (2001, August). Morphine directs T cells toward Th2 differentiation. Surgery 130(2):304–309.

    Article  PubMed  CAS  Google Scholar 

  53. Roy, S., Charboneau, R., and Barke, R. A. (1999). Morphine synergizes with LPS in an experimental sepsis model. J. Neuroimmunol. 95:107–114.

    Article  PubMed  CAS  Google Scholar 

  54. Chen, C. H., Zhang, D. H., LaPorte, J. M., and Ray, A. (2000). Cyclic AMP activates p38 mitogen-activated protein kinase in Th2 cells: Phosphorylation of GATA3 and stimulation of Th2 cytokine gene expression. J. Immunol. 165(10):5597–5605.

    PubMed  CAS  Google Scholar 

  55. Kowalski, J. (1998, August). Immunomodulatory action of class mu-, delta-and kappaopioid receptor agonists in mice. Neuropeptides 32(4):301–306.

    Article  PubMed  CAS  Google Scholar 

  56. Schulz, S. and Hollt, V. (1998, March). Opioid withdrawal activates MAP kinase in locus coeruleus neurons in morphine-dependent rats in vivo. Eur. J. Neurosci. 10(3):1196–1201.

    Article  PubMed  CAS  Google Scholar 

  57. Sharma, S. K., Klee, W. A., Nirenberg, M. (1975). Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl. Acad. Sci. USA 72:3092–3096.

    PubMed  CAS  Google Scholar 

  58. Sharma, S. K., Nirenberg, M., Klee, WA. (1975). Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl. Acad. Sci. USA 72:590–594.

    PubMed  CAS  Google Scholar 

  59. Lane-Ladd, S. B. et al. (1997). CREB in the locus coeruleus: Biochemical, physiological, and behavior evidence for a role in opiate dependence. J. Neurosci. 17:7890–7901.

    PubMed  CAS  Google Scholar 

  60. Nestler, E. J. and Aghajanian, G. K. (1997). Molecular and cellular basis of addiction. Science 278(5335):58.

    Article  PubMed  CAS  Google Scholar 

  61. Avidor-Reiss, T., Nevo, I., Levy, R., Pfeuffer, T., and Vogel, Z. (1996, August 30). Chronic opioid treatment induces adenyl cyclase V superactivation: Involvement of Gbg. J. Biol. Chem. 271(35):21309–21315.

    Article  PubMed  CAS  Google Scholar 

  62. Avidor-Reiss, T., Bayewitch, M., Levy, R., Matus-Leibovitch, N., Nevo, I., and Vogel, Z. (1995, December 15). Adenylcyclase super-sensitization in mu-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment. J. Biol. Chem. 270(50):29732–29738.

    Article  PubMed  CAS  Google Scholar 

  63. Novak, T. J. and Rothenberg, E. V. (1990, December). cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells. Proc. Natl. Acad. Sci. USA 87(23):9353–9357.

    PubMed  CAS  Google Scholar 

  64. Lee, H. J., Takemoto, N., Kurata, H., Kamogawa, Y., Miyatake, S., O’Garra, A., et al. (2000, July 3). GATA3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Th1 cells. J. Exp. Med. 192(1):105–115.

    Article  PubMed  CAS  Google Scholar 

  65. Berhow, M. T., Hiroi, N., and Nestler, E. J. (1996, August 1). Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J. Neurosci. 16(15):4707–4715.

    PubMed  CAS  Google Scholar 

  66. Ortiz, J., Harris, H. W., Guitart, X., Terwilliger, R. Z., Haycock, J.W., and Nestler, E. J. (1995). Extracellular signal-regulated protein kinases (ERKs) and ERK kinase (MEK) in brain: Regional distribution and regulation by chronic morphine. J. Neurosci. 15(2):1285–1297.

    PubMed  CAS  Google Scholar 

  67. Ma, W., Zheng, W. H., Powell, K., Jhamandas, K., and Quirion, R. (2001, October). Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: An in vitro and in vivo study. Eur. J. Neurosci. 14(7):1091–1094.

    Article  PubMed  CAS  Google Scholar 

  68. Chuang, L., Killian, K., and Chuang, R. Y. (1997). Induction of and activation of mitogen activated protein kinases of human lymphocytes as one of the signaling pathways of the immunomodulatory effects of morphine. J. Biol. Chem. 272(43): 26815–26817.

    Article  PubMed  CAS  Google Scholar 

  69. Gupta, K., Kshirsagar, S., Liming Chang, Robert Schwartz, Ping, Y. Law, Doug Yee et al. (2002, August 1). Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res. 62,4491–4498.

    PubMed  CAS  Google Scholar 

  70. Belcheva, M. M., Vogel, Z., Ignatova, E., and Avidum-Reiss, T. (1998). Opioid modulation of extracellular signal-regulated protein kinase activity is ras-dependent and involves Gbetagamma subunits. J. Neurochem. 70(2):635–645.

    Article  PubMed  CAS  Google Scholar 

  71. Turk, J. L. and Bryceson, A. D. (1971). Immunological phenomena in leprosy and related diseases. Adv. Immunol. 171(13): 209–266.

    Article  Google Scholar 

  72. Mosmann, T. R., Cherwinski, H., Bond, M. W. et al. (1986). Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348–2357.

    PubMed  CAS  Google Scholar 

  73. Beyers, A. D., van Rie, A., Adams, J., Fenhalls, G., Gie, R., and Beyers, N. (1998). Signals that regulate the host response to Mycobacterium tuberculosis. Novartis Found. Symp. 217:145–157; discussion 157–159.

    Article  PubMed  CAS  Google Scholar 

  74. Romagnani, S. (2000, July). T-cell subsets (Th1 versus Th2). Ann. Allergy Asthma Immunol. 85(1):9–18.

    Article  PubMed  CAS  Google Scholar 

  75. Rook, G. A. and Zumla, A. (2001, May). Advances in the immunopathogenesis of pulmonary tuberculosis. Curr. Opin. Pulm. Med. 7(3):116–123.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Roy, S., Wang, JH., Barke, R.A. (2005). Morphine, Th1/Th2 Differentiation, and Susceptibility to Infection. In: Friedman, H., Klein, T.W., Bendinelli, M. (eds) Infectious Diseases and Substance Abuse. Infectious Agents and Pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/0-306-48688-1_10

Download citation

Publish with us

Policies and ethics